Cost Effectiveness of Alternative Surveillance Strategies for Hepatocellular Carcinoma in Patients With Cirrhosis

Clinical Gastroenterology and Hepatology

Volumn 6, Issue 12, 2008, Pages 1418-1424

  Andersson, Karin L ^a   Salomon, Joshua A ^b   Goldie, Sue J ^b   Chung, Raymond T ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; ARTICLE; CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER SYSTEM; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; HUMAN; LIFE EXPECTANCY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; QUALITY ADJUSTED LIFE YEAR; SCREENING TEST; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; UNITED STATES;

AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; COMPUTER SIMULATION; COST-BENEFIT ANALYSIS; DIAGNOSTIC TECHNIQUES AND PROCEDURES; FIBROSIS; HEALTH CARE COSTS; HUMANS; MIDDLE AGED; QUALITY OF LIFE; UNITED STATES;

EID: 57149094014     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2008.08.005     Document Type: Article

References (56)

1. El-Serag H.B., Davila J.A., Petersen N.J., et al. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 139 (2003) 817-823
2. Sandler R.S., Everhart J.E., Donowitz M., et al. The burden of selected digestive diseases in the United States. Gastroenterology 122 (2002) 1500-1511
3. Chalasani N., Said A., Ness R., et al. Screening for hepatocellular carcinoma in patients with cirrhosis in the United States: results of a national survey. Am J Gastroenterol 94 (1999) 2224-2229
4. Cottone M., Turri M., Caltagirone M., et al. Screening for hepatocellular carcinoma in patients with Child's A cirrhosis: an 8-year prospective study by ultrasound and alphafetoprotein. J Hepatol 21 (1994) 1029-1034
5. Pateron D., Ganne N., Trinchet J.C., et al. Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. J Hepatol 20 (1994) 65-71
6. Sangiovanni A., Del Ninno E., Fasani P., et al. Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology 126 (2004) 1005-1014
7. Toyoda H., Kumada T., Kiriyama S., et al. Impact of surveillance on survival of patients with initial hepatocellular carcinoma: a study from Japan. Clin Gastroenterol Hepatol 4 (2006) 1170-1176
8. Bruix J., and Sherman M. Management of hepatocellular carcinoma. Hepatology 42 (2005) 1208-1236
9. Saab S., Ly D., Nieto J., et al. Hepatocellular carcinoma screening in patients waiting for liver transplantation: a decision analytic model. Liver Transpl 9 (2003) 672-681
10. Sarasin F.P., Giostra E., and Hadengue A. Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis. Am J Med 101 (1996) 422-434
11. Arguedas M.R., Chen V.K., Eloubeidi M.A., et al. Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis. Am J Gastroenterol 98 (2003) 679-690
12. Lin O.S., Keeffe E.B., Sanders G.D., et al. Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C. Aliment Pharmacol Ther 19 (2004) 1159-1172
13. Patel D., Terrault N.A., Yao F.Y., et al. Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus-related cirrhosis. Clin Gastroenterol Hepatol 3 (2005) 75-84
14. Thompson Coon J., Rogers G., Hewson P., et al. Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis. Health Technol Assess 11 (2007) 1-206
15. Lencioni R., Cioni D., Crocetti L., et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 234 (2005) 961-967
16. Mazzaferro V., Regalia E., Doci R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334 (1996) 693-699
17. Miller W.J., Baron R.L., Dodd G.D., et al. Malignancies in patients with cirrhosis: CT sensitivity and specificity in 200 consecutive transplant patients. Radiology 193 (1994) 645-650
18. de Ledinghen V., Laharie D., Lecesne R., et al. Detection of nodules in liver cirrhosis: spiral computed tomography or magnetic resonance imaging?. A prospective study of 88 nodules in 34 patients. Eur J Gastroenterol Hepatol 14 (2002) 159-165
19. D'Amico G., Garcia-Tsao G., and Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 44 (2006) 217-231
20. Salerno F., Borroni G., Moser P., et al. Survival and prognostic factors of cirrhotic patients with ascites: a study of 134 outpatients. Am J Gastroenterol 88 (1993) 514-519
21. D'Amico G., Morabito A., Pagliaro L., et al. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci 31 (1986) 468-475
22. Zoli M., Magalotti D., Bianchi G., et al. Efficacy of a surveillance program for early detection of hepatocellular carcinoma. Cancer 78 (1996) 977-985
23. Bolondi L., Sofia S., Siringo S., et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut 48 (2001) 251-259
24. Llovet J.M., Bustamante J., Castells A., et al. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 29 (1999) 62-67
25. Barbara L., Benzi G., Gaiani S., et al. Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology 16 (1992) 132-137
26. Cottone M., Virdone R., Fusco G., et al. Asymptomatic hepatocellular carcinoma in Child's A cirrhosis. A comparison of natural history and surgical treatment. Gastroenterology 96 (1989) 1566-1571
27. Ebara M., Ohto M., Shinagawa T., et al. Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in 22 patients. Gastroenterology 90 (1986) 289-298
28. Sheu J.C., Sung J.L., Chen D.S., et al. Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. Gastroenterology 89 (1985) 259-266
29. Rizzi P.M., Kane P.A., Ryder S.D., et al. Accuracy of radiology in detection of hepatocellular carcinoma before liver transplantation. Gastroenterology 107 (1994) 1425-1429
30. Miller W.J., Federle M.P., and Campbell W.L. Diagnosis and staging of hepatocellular carcinoma: comparison of CT and sonography in 36 liver transplantation patients. AJR Am J Roentgenol 157 (1991) 303-306
31. Dodd G.D., Miller W.J., Baron R.L., et al. Detection of malignant tumors in end-stage cirrhotic livers: efficacy of sonography as a screening technique. AJR Am J Roentgenol 159 (1992) 727-733
32. Bennett G.L., Krinsky G.A., Abitbol R.J., et al. Sonographic detection of hepatocellular carcinoma and dysplastic nodules in cirrhosis: correlation of pretransplantation sonography and liver explant pathology in 200 patients. AJR Am J Roentgenol 179 (2002) 75-80
33. Libbrecht L., Bielen D., Verslype C., et al. Focal lesions in cirrhotic explant livers: pathological evaluation and accuracy of pretransplantation imaging examinations. Liver Transpl 8 (2002) 749-761
34. Lim J.H., Kim C.K., Lee W.J., et al. Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic livers: accuracy of helical CT in transplant patients. AJR Am J Roentgenol 175 (2000) 693-698
35. Peterson M.S., Baron R.L., Marsh J.W., et al. Pretransplantation surveillance for possible hepatocellular carcinoma in patients with cirrhosis: epidemiology and CT-based tumor detection rate in 430 cases with surgical pathologic correlation. Radiology 217 (2000) 743-749
36. Brancatelli G., Baron R.L., Peterson M.S., et al. Helical CT screening for hepatocellular carcinoma in patients with cirrhosis: frequency and causes of false-positive interpretation. AJR Am J Roentgenol 180 (2003) 1007-1014
37. Gupta S., Bent S., and Kohlwes J. Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis. Ann Intern Med 139 (2003) 46-50
38. Trevisani F., D'Intino P.E., Morselli-Labate A.M., et al. Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. J Hepatol 34 (2001) 570-575
39. Krinsky G.A., Lee V.S., Theise N.D., et al. Transplantation for hepatocellular carcinoma and cirrhosis: sensitivity of magnetic resonance imaging. Liver Transpl 8 (2002) 1156-1164
40. Krinsky G.A., Lee V.S., Theise N.D., et al. Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and explantation correlation. Radiology 219 (2001) 445-454
41. Llovet J.M., Fuster J., and Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 30 (1999) 1434-1440
42. Yao F.Y., Ferrell L., Bass N.M., et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 33 (2001) 1394-1403
43. Fong Y., Sun R.L., Jarnagin W., et al. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 229 (1999) 790-799
44. Poon R.T., Fan S.T., Lo C.M., et al. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 235 (2002) 373-382
45. Franco D., Capussotti L., Smadja C., et al. Resection of hepatocellular carcinomas. Results in 72 European patients with cirrhosis. Gastroenterology 98 (1990) 733-738
46. Tateishi R., Shiina S., Teratani T., et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 103 (2005) 1201-1209
47. Lencioni R.A., Allgaier H.P., Cioni D., et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 228 (2003) 235-240
48. Livraghi T., Solbiati L., Meloni M.F., et al. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 226 (2003) 441-451
49. Simonetti R.G., Liberati A., Angiolini C., et al. Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials. Ann Oncol 8 (1997) 117-136
50. Nowak A.K., Chow P.K., and Findlay M. Systemic therapy for advanced hepatocellular carcinoma: a review. Eur J Cancer 40 (2004) 1474-1484
51. El-Serag H.B., Siegel A.B., Davila J.A., et al. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study. J Hepatol 44 (2006) 158-166
52. Bennett W.G., Inoue Y., Beck J.R., et al. Estimates of the cost-effectiveness of a single course of interferon-alpha 2b in patients with histologically mild chronic hepatitis C. Ann Intern Med 127 (1997) 855-865
53. Younossi Z.M., Singer M.E., McHutchison J.G., et al. Cost effectiveness of interferon alpha2b combined with ribavirin for the treatment of chronic hepatitis C. Hepatology 30 (1999) 1318-1324
54. Kim W.R., Poterucha J.J., Hermans J.E., et al. Cost-effectiveness of 6 and 12 months of interferon-alpha therapy for chronic hepatitis C. Ann Intern Med 127 (1997) 866-874
55. Lindfors K.K.R., and Rosenquist C.J. The cost-effectiveness of mammographic screening strategies. JAMA 274 (1995) 881-884
56. Frazier A.L., Colditz G.A., Fuchs C.S., et al. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA 284 (2000) 1954-1961